Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. 2009

Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USA.

We performed a double-blind, crossover-design study to assess the tolerability and efficacy of pregabalin (PGB) in patients with essential tremor (ET). Twenty patients (11 women; mean age of 62.2+/-12.7 years, mean ET duration of 25.5+/-14.9 years) with ET were randomized for treatment with PGB (150-600 mg/day) or placebo, titrated over 6 weeks. Identical assessments of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) (primary endpoint), Clinical Global Impression of Change (CGI-C), Quality of Life in Essential Tremor Questionnaire (QUEST), Hamilton Anxiety Scale (HAM-A), and a sleep hygiene questionnaire (HD-16) were made at the baseline, at the end of treatment periods for both drug and placebo, and following the 2-week washout period preceding crossover. We found no improvement in any of the TRS measures and a statistically significant worsening of QUEST scores while patients were taking PGB. Adverse events were similar in frequency to previously published studies of PGB, the most common being drowsiness and dizziness.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069583 Pregabalin A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. (R-)-3-isobutyl GABA,(S)-3-(aminomethyl)-5-methylhexanoic acid,(S+)-3-isobutyl GABA,3-(aminomethyl)-5-methylhexanoic acid,3-isobutyl GABA,CI 1008,CI-1008,Lyrica,1008, CI,3 isobutyl GABA,CI1008,GABA, 3-isobutyl
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
January 2006, Clinical neuropharmacology,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
December 2020, Toxins,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
August 2007, Movement disorders : official journal of the Movement Disorder Society,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
October 2004, Movement disorders : official journal of the Movement Disorder Society,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
March 2006, Neurology,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
February 2013, Movement disorders : official journal of the Movement Disorder Society,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
October 2008, Headache,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
January 2008, Clinical neuropharmacology,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
January 2015, Neurology,
Joseph M Ferrara, and Christopher Kenney, and Anthony L Davidson, and Lina Shinawi, and Abigail M Kissel, and Joseph Jankovic
July 2002, Neurology,
Copied contents to your clipboard!